Nanalysis Scientific Corp.

OTC:NSCIF

0.3189 (USD) • At close November 15, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019201820172016
Revenue 45.49528.46624.82116.0437.8748.3648.3817.6685.252
Cost of Revenue 32.74924.49514.3525.8032.7072.3042.9832.7742.147
Gross Profit 12.7463.97110.46910.245.1676.065.3984.8953.105
Gross Profit Ratio 0.280.1390.4220.6380.6560.7250.6440.6380.591
Reseach & Development Expenses 0.5440.6791.4650.6430.4760000
General & Administrative Expenses 9.67311.04112.4146.143.5122.7742.2561.3151.325
Selling & Marketing Expenses 1.6211.3521.9362.1431.112.4532.5151.961.566
SG&A 11.29412.39314.358.2836.6445.2274.7713.2752.891
Other Expenses 4.3534.3654.5642.5051.6810.7750.62700
Operating Expenses 16.19115.59220.37911.4318.8015.9945.3983.2752.891
Operating Income -3.445-11.621-9.91-1.191-3.6340.0580.4611.620.213
Operating Income Ratio -0.076-0.408-0.399-0.074-0.4620.0070.0550.2110.041
Total Other Income Expenses Net -10.19-5.174-0.489-0.581-0.341-1.457-0.325-0.167-0.077
Income Before Tax -13.635-16.795-10.399-1.772-3.975-1.3990.1361.4520.136
Income Before Tax Ratio -0.3-0.59-0.419-0.11-0.505-0.1670.0160.1890.026
Income Tax Expense -0.022-0.011-0.4840-0.2970.2610.0620.210.143
Net Income -13.613-16.784-9.915-1.772-3.678-1.660.074-0.172-0.025
Net Income Ratio -0.299-0.59-0.399-0.11-0.467-0.1980.009-0.022-0.005
EPS -0.12-0.16-0.11-0.033-0.056-0.030.001-0.17-0.025
EPS Diluted -0.12-0.16-0.11-0.033-0.056-0.030.001-0.17-0.025
EBITDA -7.664-8.848-5.2611.376-1.8640.9030.661.7840.324
EBITDA Ratio -0.168-0.311-0.2120.086-0.2370.1080.0790.2330.062